language:
Find link is a tool written by Edward Betts.searching for hsp90 inhibitor 14 found (19 total)
alternate case: Hsp90 inhibitor
Chaperome
(733 words)
[view diff]
exact match in snippet
view article
find links to article
adapting to stress including hypoxia and heat. The small molecule Hsp90 inhibitor, PU-H71, has been found to have a preferential binding to Hsp90 whenRadicicol (269 words) [view diff] case mismatch in snippet view article find links to article
"Functional Characterization of the Biosynthesis of Radicicol, an Hsp90 Inhibitor Resorcylic Acid Lactone from Chaetomium chiversii". Chemistry & BiologyLYN (3,807 words) [view diff] case mismatch in snippet view article find links to article
rheostat that modulates signaling rather than as a binary on-off switch. HSP90 inhibitor NVP-BEP800 has been described to affect stability of LYN kinase andProto-oncogene tyrosine-protein kinase Src (2,795 words) [view diff] case mismatch in snippet view article find links to article
bosutinib, bafetinib, Saracatinib(AZD-0530), XLl-999, KX01 and XL228. HSP90 inhibitor NVP-BEP800 has been described to affect stability of Src tyrosine kinasePaul Workman (scientist) (955 words) [view diff] exact match in snippet view article
cells, in particular, molecular chaperones such as Hsp90. The leading Hsp90 inhibitor was discovered by Workman's team at ICR in collaboration with VernalisTyrosin-protein kinase Lck (4,466 words) [view diff] case mismatch in snippet view article find links to article
have some impact on its therapeutic effects in canine mastocytoma. HSP90 inhibitor NVP-BEP800 has been described to affect stability of the LCK kinaseVernalis Research (1,160 words) [view diff] exact match in snippet view article find links to article
July 2015. Additionally, luminespib (AUY922) is a novel intravenous Hsp90 inhibitor with the potential to target a range of cancers, which arose from aFNIP1 (707 words) [view diff] exact match in snippet view article find links to article
Trepel JB, Whitesell L, Picard D (July 2018). "Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approachesClusterin (2,433 words) [view diff] no match in snippet view article find links to article
that blocks the CLU mRNA transcript, enhanced heat-shock protein 90 (HSP90) inhibitor activity by suppressing the heat-shock response in castrate-resistantLutetium (177Lu) chloride (678 words) [view diff] case mismatch in snippet view article
Lundsten S, Spiegelberg D, Stenerlöw B, Nestor M (December 2019). "The HSP90 inhibitor onalespib potentiates 177Lu‑DOTATATE therapy in neuroendocrine tumorList of pharmaceutical compound number prefixes (1,656 words) [view diff] case mismatch in snippet view article find links to article
Archived from the original on 2012-04-16. Retrieved 2012-04-17. "Exelixis HSP90 inhibitor XL888". Archived from the original on 2016-09-18. Retrieved 2016-09-16Heat shock protein (5,525 words) [view diff] exact match in snippet view article find links to article
HSPs, especially Hsp90 show promise as anticancer agents. The potent Hsp90 inhibitor 17-AAG was in clinical trials for the treatment of several types ofHsp70 (5,631 words) [view diff] exact match in snippet view article find links to article
et al. (June 2018). "Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art". Biomedicine & PharmacotherapyHeat shock protein 90kDa alpha (cytosolic), member A1 (8,175 words) [view diff] exact match in snippet view article
most amenable to inhibitor generation. To date, there are 23 active Hsp90 inhibitor oncology trials, and 13 HSP90 inhibitors are currently undergoing clinical